Penn's Center for Education and Research on Therapeutics will receive $4 million to continue research into infection therapies, according to a press release.
"This award allows us to continue and expand our work in improving the use of antibiotics, incorporating the new tools of health IT," said Penn CERT director Brian Strom. "It is an indication of Penn's national stature in patient safety, especially in the use of drugs."
The award is part of a federal government's multi-million dollar expansion of the Agency for Healthcare Research and Quality's CERT program, which is a part of the Department of Health and Human Services.
"This expansion allows AHRQ to build a strong evidence base that consumers, clinicians and others can use to make critical treatment decisions about therapeutic products and interventions," said AHRQ Director Carolyn Clancy. "The increased number and breadth of expertise in the CERTs will broaden the range of knowledge to help the health-care system make measurable improvements in the quality and safety of medications and other treatments and health care."
Penn CERT includes Penn's Center for Clinical Epidemiology and Biostatistics, the Leonard Davis Institute, the Hospital of the University of Pennsylvania and Children's Hospital of Pennsylvania.
The Daily Pennsylvanian is an independent, student-run newspaper. Please consider making a donation to support the coverage that shapes the University. Your generosity ensures a future of strong journalism at Penn.
DonatePlease note All comments are eligible for publication in The Daily Pennsylvanian.